TransCirc 2.0: a multi-species resource for translatable circular RNAs and cognate translation products
Nucleic Acids Research · 13.11.2026
DOI: 10.1093/nar/gkag1149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 13.11.2026. Verfasst von Dan Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Innovative Center of RNA Medicine, School of Life Sciences, Southern University of Science and Technology, Shenzhen 51…. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, BMGF-NSFC Joint Project on Vaccine Research and Development.
Abstract (Originalsprache)
TransCirc is an evidence-integrated database for evaluating the translation potential of circular RNAs (circRNAs) and their putative products. Here, we present TransCirc 2.0, a major update that expands this resource from a primarily human-focused database to 10 vertebrate species, comprising more than 2.8 million circRNAs and increasing coverage by approximately 10-fold through the integration of standardized full-length circRNA sequences. Within the original multi-evidence framework, we incorporate additional evidence, including translation initiation sites, internal ribosome entry sites, N6-methyladenosine, ribosome/polysome association, and mass spectrometry (MS), together with circRNA-specific open reading frame and sequence-composition annotations. In light of recent advances in AI-based RNA modeling, we further incorporate multiple regulatory features predicted by TranslationAI and LAMAR. The circRNA-encoded proteins are further annotated for degron-associated stability and degradation properties, while MS-supported peptides are evaluated for potential MHC-I presentation. Collectively, these updates establish a cross-species framework linking full-length circRNA sequences with multi-level translation evidence and downstream product annotations, supporting systematic evaluation of circRNA translation potential and putative translation products. TransCirc 2.0 is freely available at https://www.biosino.org/transcirc/.
Autor:innen und Institutionen
- Department of Systems Biology, Innovative Center of RNA Medicine, School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, China.
- Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai 200031, China.
- Key University Laboratory of RNA Medicine of Guangdong, Shenzhen 518055, China.
ORCID-Profile: Yunchao Ling, Xiaojuan Fan, Guoqing Zhang, Zefeng Wang
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- BMGF-NSFC Joint Project on Vaccine Research and Development
- Shanghai Science and Technology Innovation Action Plan
- Shanghai CirCode Biomed
- Shanghai Oriental Talents Program
Zitieren
APA
Xie, D., Ling, Y., Li, D., Zhou, H., Fan, X., Cao, R., Zhang, G., & Wang, Z. (2026). TransCirc 2.0: a multi-species resource for translatable circular RNAs and cognate translation products. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag1149
Vancouver
Xie D, Ling Y, Li D, Zhou H, Fan X, Cao R, et al. TransCirc 2.0: a multi-species resource for translatable circular RNAs and cognate translation products. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag1149
BibTeX
@article{Xie2026,
author = {Xie, Dan and Ling, Yunchao and Li, Daoqian and Zhou, Hanwen and Fan, Xiaojuan and Cao, Ruifang and Zhang, Guoqing and Wang, Zefeng},
title = {TransCirc 2.0: a multi-species resource for translatable circular RNAs and cognate translation products},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag1149}
}
EUVIMED